As of May 14, 2026, Candel Therapeutics's top three insider holders are Estuardo Aguilar-Cordova (Chief Scientific Officer, 1.10Mn shares), Laura K. Aguilar (Chief Medical Officer, 1.03Mn shares), Estuardo Aguilar-Cordova (TenPercentOwner, 283.79K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Estuardo Aguilar-Cordova | Chief Scientific Officer | 1,097,032 | 0 | 10 May, 2022 |
| Laura K. Aguilar | Chief Medical Officer | 1,033,840 | 0 | 10 May, 2022 |
| Estuardo Aguilar-Cordova | - | 162,929 | 120,861 | 25 Feb, 2025 |
| Christopher Martell | - | 0 | 283,514 | 02 Aug, 2021 |
| Paul Peter Tak | Chief Executive Officer | 268,566 | 0 | 26 Jun, 2025 |
| Jason Amello | Chief Financial Officer | 202,009 | 0 | 30 Nov, 2023 |
| Christopher Martell | - | 0 | 152,000 | 17 Feb, 2023 |
| Christopher Martell | - | 152,000 | 0 | 12 Dec, 2022 |
| Christopher Martell | - | 0 | 111,349 | 26 Jun, 2025 |
| Francesca Barone | Chief Scientific Officer | 100,809 | 0 | 26 Jun, 2025 |
| Seshu Tyagarajan | Chief Technology Officer | 90,865 | 0 | 26 Jun, 2025 |
| William Garrett Nichols | Chief Medical Officer | 52,493 | 0 | 30 Jul, 2025 |
| Charles Schoch | Chief Financial Officer | 43,391 | 0 | 26 Jun, 2025 |
| John J Canepa | Chief Financial Officer | 10,125 | 0 | 02 Aug, 2021 |
| Nathan Caffo | Chief Business Officer | 6,000 | 0 | 02 Aug, 2021 |
| Gary J. Nabel | - | 5,353 | 0 | 26 Jun, 2025 |
| Nicoletta Loggia | - | 2,141 | 0 | 26 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 31 Mar, 2026 | Nicoletta Loggia | Stock Option (Right to Buy) | A | 779 | $4.11 | 779 | D | A |
| 26 Jan, 2026 | Seshu Tyagarajan | Stock Option (Right to Buy) | A | 154,000 | $0.00 | 154,000 | D | A |
| 26 Jan, 2026 | Charles Schoch | Stock Option (Right to Buy) | A | 232,000 | $0.00 | 232,000 | D | A |
| 26 Jan, 2026 | William Garrett Nichols | Stock Option (Right to Buy) | A | 136,500 | $0.00 | 136,500 | D | A |
| 26 Jan, 2026 | Paul Peter Tak | Stock Option (Right to Buy) | A | 629,000 | $0.00 | 629,000 | D | A |
| 26 Jan, 2026 | Francesca Barone | Stock Option (Right to Buy) | A | 232,000 | $0.00 | 232,000 | D | A |
| 28 Jul, 2025 | William Garrett Nichols | Common Stock | A | 937 | $1.29 | 53,430 | D | M |
| 28 Jul, 2025 | William Garrett Nichols | Common Stock | D | 937 | $6.98 | 52,493 | D | S |
| 28 Jul, 2025 | William Garrett Nichols | Stock Option (Right to Buy) | D | 937 | $0.00 | 29,377 | D | M |
| 30 Jun, 2025 | William Garrett Nichols | Common Stock | A | 781 | $1.29 | 53,274 | D | M |
| 30 Jun, 2025 | William Garrett Nichols | Common Stock | D | 781 | $5.04 | 52,493 | D | S |
| 30 Jun, 2025 | William Garrett Nichols | Stock Option (Right to Buy) | D | 781 | $0.00 | 30,314 | D | M |
| 25 Jun, 2025 | Charles Schoch | Common Stock | A | 5,353 | $4.67 | 43,391 | D | A |
| 25 Jun, 2025 | Nicoletta Loggia | Common Stock | A | 2,141 | $4.67 | 2,141 | D | A |
| 25 Jun, 2025 | Gary J. Nabel | Common Stock | A | 5,353 | $4.67 | 5,353 | D | A |
| 25 Jun, 2025 | Christopher Martell | Common Stock | A | 111,349 | $4.67 | 111,349 | I | A |
| 25 Jun, 2025 | Paul Peter Tak | Common Stock | A | 42,826 | $4.67 | 268,566 | D | A |
| 25 Jun, 2025 | Seshu Tyagarajan | Common Stock | A | 5,353 | $4.67 | 90,865 | D | A |
| 25 Jun, 2025 | Francesca Barone | Common Stock | A | 4,282 | $4.67 | 100,809 | D | A |
| 20 Jun, 2025 | Charles Schoch | Stock Option (Right to Buy) | A | 50,000 | $0.00 | 50,000 | D | A |